Oculis Holding AG Ordinary shares (OCS) financial statements

Healthcare · Biotechnology · Market cap $448M

Oculis Holding AG Ordinary shares reported revenue of 1M CHF in fiscal 2025, up 3.8% a year over 5 years.

Net income was -99M CHF and the operating margin -6811.7%, against -1242.3% in 2020.

Free cash flow was -68M CHF.

The diluted share count rose 1925% over the period (dilution).

Revenue and free cash flow

Fiscal years, $ billions (CHF).

Embed this chart

Free to use in articles and newsletters with the source line. Paste this HTML:

<iframe src="https://investingly.io/embed/OCS/financials" width="100%" height="330" style="border:0;max-width:680px" title="Oculis Holding AG Ordinary shares revenue and free cash flow" loading="lazy"></iframe>
<p style="font-size:13px">Source: <a href="https://investingly.io/stocks/OCS/financials">Oculis Holding AG Ordinary shares financials</a> on Investingly</p>

Income statement

Fiscal years, in CHF, from Oculis Holding AG Ordinary shares's 10-K filings with the SEC.

Fiscal year	2020	2021	2022	2023	2024	2025
Revenue	993,000 CHF	960,000 CHF	912,000 CHF	883,000 CHF	686,000 CHF	1M CHF
Research and development	9M CHF	10M CHF	22M CHF	29M CHF	52M CHF	57M CHF
Selling, general and admin	4M CHF	5M CHF	11M CHF	17M CHF	22M CHF	26M CHF
Operating income	-12M CHF	-13M CHF	-32M CHF	-81M CHF	-73M CHF	-82M CHF
Interest expense	18,000 CHF	75,000 CHF	54,000 CHF	1M CHF	639,000 CHF	833,000 CHF
Pre-tax income	-15M CHF	-19M CHF	-39M CHF	-89M CHF	-86M CHF	-99M CHF
Income tax	83,000 CHF	27,000 CHF	55,000 CHF	107,000 CHF	-160,000 CHF	-186,000 CHF
Net income	-15M CHF	-19M CHF	-39M CHF	-89M CHF	-86M CHF	-99M CHF
EPS (diluted)	-5.77 CHF	-5.84 CHF	-11.32 CHF	-2.97 CHF	-2.12 CHF	-1.89 CHF
Diluted shares	3M	3M	3M	30M	40M	52M
Operating margin	-1242.3%	-1378.3%	-3550.0%	-9140.9%	-10671.1%	-6811.7%
Net margin	-1497.8%	-1932.5%	-4243.2%	-10056.9%	-12503.9%	-8253.3%

Balance sheet

Fiscal years, in CHF, from Oculis Holding AG Ordinary shares's 10-K filings with the SEC.

Fiscal year	2020	2021	2022	2023	2024	2025
Cash and short-term investments	5M CHF	46M CHF	20M CHF	38M CHF	28M CHF	81M CHF
Total current assets	—	48M CHF	24M CHF	101M CHF	105M CHF	219M CHF
Property, plant and equipment	—	431,000 CHF	365,000 CHF	288,000 CHF	385,000 CHF	534,000 CHF
Total assets	—	58M CHF	37M CHF	114M CHF	120M CHF	236M CHF
Total current liabilities	—	4M CHF	12M CHF	19M CHF	44M CHF	37M CHF
Total liabilities	—	119M CHF	135M CHF	21M CHF	47M CHF	40M CHF
Shareholders' equity	-44M CHF	-61M CHF	-98M CHF	94M CHF	73M CHF	196M CHF
Net debt	-5M CHF	-46M CHF	-20M CHF	-38M CHF	-28M CHF	-81M CHF

Cash flow

Fiscal years, in CHF, from Oculis Holding AG Ordinary shares's 10-K filings with the SEC.

Fiscal year	2020	2021	2022	2023	2024	2025
Operating cash flow	-12M CHF	-14M CHF	-25M CHF	-55M CHF	-49M CHF	-66M CHF
Capital spending	19,000 CHF	28,000 CHF	4M CHF	48,000 CHF	230,000 CHF	1M CHF
Free cash flow	-12M CHF	-14M CHF	-29M CHF	-55M CHF	-49M CHF	-68M CHF
Stock-based compensation	328,000 CHF	328,000 CHF	804,000 CHF	4M CHF	10M CHF	16M CHF
Free cash flow margin	-1213.3%	-1443.0%	-3138.4%	-6238.4%	-7164.6%	-5645.7%

Every line, every quarterThe deep dive has fifteen-plus years of statements, quarterly results, charts and valuation models for OCS.

Open OCS in Investingly

Questions

What was Oculis Holding AG Ordinary shares's revenue in 2025?

1M CHF in fiscal 2025, from its 10-K filing.

How much free cash flow does Oculis Holding AG Ordinary shares generate?

-68M CHF in fiscal 2025 (operating cash flow minus capital spending).

From Oculis Holding AG Ordinary shares's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.